Health comms agency Hive launched
February 27, 2008Medical Communications
A group of experienced healthcare communications executives have launched Hive which they claim represents a 'next generation' of agency to …
Boehringer Ingelheim’s anti-clotting pill ready for launch
February 15, 2008Research and Development
Boehringer Ingelheim's Pradaxa is expected to gain final regulatory approval shortly and could make a major impact in the anti-thrombosis …
Latest news from Datamonitor
February 15, 2008Research and Development
Introgen and Moffitt initiate Phase II lung cancer trial Introgen Therapeutics and Moffitt Cancer Center have reported that a randomized, …
Generics and Avandia decline will hold GSK back
February 8, 2008Sales and Marketing
GlaxoSmithKline's chief executive-in-waiting Andrew Witty faces a difficult first year at the helm of the company after sales growth was …
Vectibix launched for bowel cancer in UK
February 8, 2008Sales and Marketing colorectal cancer
Vectibix, a new treatment for advanced colorectal cancer, has been launched in the UK. The treatment from Amgen was first …
NHS launches new online health A-Z index
February 8, 2008Medical Communications
NHS Choices, the online 'front door' for the NHS, has released an updated online information resource aimed at helping the …
Ministers press GPs over surgery hours
February 8, 2008Government and BMA relations have hit an all time low, with the doctor's association accusing ministers of undermining its position …
Wellcome Trust boosts medical research funding
February 8, 2008Research and Development
Research charity the Wellcome Trust will increase its funding for medical research by more than £1 billion over the next …
Biovitrum to focus on specialist care
February 8, 2008Research and Development
Swedish biopharmaceutical company Biovitrum is to turn its back on mass market disease areas and re-focus around specialist care projects. …
Latest news from Datamonitor
February 6, 2008Sales and Marketing Coronado Biosciences, rnai
Coronado Biosciences’ cancer treatment effective in animal modelsCoronado Biosciences has reported that the Bcl-2 inhibitor, apogossypol, effectively killed a variety …
Collaborations with diagnostic firms ‘crucial to oncology progress’
February 6, 2008Research and Development
Pharma companies should engage diagnostics companies in early phase talks if they want to fast-track innovative new cancer treatments to …
Takeda snaps up Amgen products
February 6, 2008Sales and Marketing
Takeda has bought marketing rights to 13 of Amgen's early stage products, boosting its flagging pipeline and letting Amgen recoup …
Government and industry agree on collaboration guidelines
February 1, 2008New guidelines to help NHS bodies work with the pharmaceutical industry have been agreed after months of negotiation, and could …
New consortium to run NHS clinical audit programme
February 1, 2008The Department of Health has reorganised the way audits of patient care are carried out, handing the running of its …
Torisel poised to gain lymphoma licence
February 1, 2008Sales and Marketing
Wyeth's new cancer drug Torisel is set to gain approval for use in patients with a rare and difficult to …
Tamiflu resistance hits Roche
February 1, 2008Sales and Marketing
Sales of the blockbuster flu treatment Tamiflu could receive a setback from new data showing significant resistance to the drug. …
AstraZeneca sales strong despite Nexium’s decline
February 1, 2008Sales and Marketing
AstraZeneca achieved sales growth of 12% in 2007, despite a worrying decline in sales from its biggest seller, anti-ulcer drug …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
